R&D Systems™ Recombinant Human alpha-Synuclein Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human alpha-Synuclein Protein is derived from E. coli. The Recombinant Human alpha-Synuclein Protein has been validated for the following applications: Bioactivity.

Order Info

Ships at ambient temperature.

Specifications

• Accession Number: P37840.1
• For Use With (Application): Bioactivity
• Formulation: Supplied as a 0.2 μm filtered solution in HEPES, NaCl and DTT.
• Gene ID (Entrez): 1401
• Molecular Weight (g/mol): 14 kDa
• Quantity: 500μg
• Source: E. coli-derived human alpha-Synuclein protein Met1 - Ala140
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -70°C as supplied. 3 months, -70°C under sterile conditions after opening.
• Regulatory Status: RUO
• Common Name: alpha-Synuclein; Lewy body) 4; MGC110988; NACP; non A-beta component of AD amyloid; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor; non-A4 component of amyloid; PARK1; PARK4; PD1; SNCA; synuclein, alpha (non A4 component of amyl
• Biological Activity: Reaction conditions will need to be optimized for each specific application.We recommend an initial Recombinant Humanalpha -Synuclein concentration of 0.5-2.5μM.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie Blue stain.

For Research Use Only.